REGENTIS BIOMATERIALS LTD. - RGNT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC | History | New | 300,000 | 916 | 0.12% | — | 1 | +300,000 | New | Q1 2026 | Apr 30, 2026 |
| Rosalind Advisors, Inc. | History | No change | 251,510 | 768 | 0.31% | 0.6% | 2 | 0 | 0.0% | Q1 2026 | May 14, 2026 |
| UBS Group AG | History | New | 334 | 1 | 0.0% | — | 3 | +334 | New | Q1 2026 | May 05, 2026 |
| Warberg Asset Management LLC | History | Closed out | 0 | 0 | — | 0.02% | — | -19,093 | -100.0% | Q1 2026 | May 07, 2026 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -10,412 | -100.0% | Q1 2026 | May 15, 2026 |